PDCD1 and neoplasm: Rice et al. demonstrated that immunotherapy with an adenoviral vector vaccine, encoding the HPV16 E6 and E7 genes, in combination with PD-1 checkpoint inhibition resulted in delayed tumor growth and a significant improvement in survival compared to the controls [69].